Porto liver meeting – Vascular liver diseases 23.6.18

[Akash Shukla]

8:00 | Registry
8:25 | Opening ceremony
Metabolic diseases and vascular liver involvement
8:30 The liver: a “new” target-organ for diabetes? – Laure Elkrief
8:50 |Systemic atherosclerosis and the liver: who is the culprit and who is the victim?- Pierre-Emmanuel Rautou
9:10 |Impact of statins on liver fibrosis – Jonel Trebicka
9:30 |Clinical Case and discussion – André Carvalho

Cirrhosis and procoagulant environment

9:50 | Coagulation imbalance: what is known and what is there to come?- Ton Lisman
10:10 |Extrasplanchnic vein thrombosis: from prevention to treatment -Marco Senzolo
10:30 | Work up to do in a thrombotic event – Eugénia Cruz
10:50 | Clinical Case and discussion – Graziela Carvalheiras
11:10 | Coffee-break
Portal Vein Thrombosis in cirrhosis
11:50 |From known risk factors to predictive scores – Filipe Nery
12:10 |From theory to practice: Does PVT lead to liver disease decompensation?
12:30 |PVT and OLT: pre and post – Sarwa Darwish Murad
12:50 |Anticoagulation treatment: NOACs – are we still far from using them? – Andrea de Gottardi 13:10 |Clinical Case and discussion – Diana Valadares
13:30 |Lunch
Portal hypertension
14:20 | How to measure it: direct and indirect tools – Juan Carlos Garcia-Pagan
14:40 | HVPG-guided therapy – Candid Villanueva
15:00 | Controversies with the use of beta-blockers – from the present to the future – Arnulf Ferlitsch
15:20 | Clinical Case and discussion – Alexandre Pinto
Rare vascular liver diseases: practical flowchart from diagnosis to treatment
15:40 | Portal-Sinusoidal Disease – Fanny Turon
16:00 | Abernethy malformation – Anna Baiges
16:20 | Budd-Chiari Syndrome – Aurélie Plessier
16:40 | Clinical Case and discussion – Ermelinda Silva
17:00 | Closing ceremony

[Author]

Posts